JP2010524910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010524910A5 JP2010524910A5 JP2010503583A JP2010503583A JP2010524910A5 JP 2010524910 A5 JP2010524910 A5 JP 2010524910A5 JP 2010503583 A JP2010503583 A JP 2010503583A JP 2010503583 A JP2010503583 A JP 2010503583A JP 2010524910 A5 JP2010524910 A5 JP 2010524910A5
- Authority
- JP
- Japan
- Prior art keywords
- sfrp3
- therapeutically effective
- derivative
- fragment
- wounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000000996 Secreted frizzled-related protein 3 Human genes 0.000 claims 38
- 108010018632 frizzled related protein-3 Proteins 0.000 claims 38
- 239000012634 fragment Substances 0.000 claims 35
- 206010052428 Wound Diseases 0.000 claims 17
- 208000027418 Wounds and injury Diseases 0.000 claims 17
- 206010016654 Fibrosis Diseases 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 6
- 230000004761 fibrosis Effects 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 4
- 230000037390 scarring Effects 0.000 claims 4
- 238000001356 surgical procedure Methods 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 3
- 230000009467 reduction Effects 0.000 claims 3
- 230000001629 suppression Effects 0.000 claims 3
- 208000032544 Cicatrix Diseases 0.000 claims 2
- 108010043958 Peptoids Proteins 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000003176 fibrotic effect Effects 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 231100000241 scar Toxicity 0.000 claims 2
- 230000037387 scars Effects 0.000 claims 2
- 210000001835 viscera Anatomy 0.000 claims 2
- 206010054045 Anterior capsule contraction Diseases 0.000 claims 1
- 208000002177 Cataract Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 150000008574 D-amino acids Chemical class 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 101000864788 Homo sapiens Secreted frizzled-related protein 3 Proteins 0.000 claims 1
- 206010023421 Kidney fibrosis Diseases 0.000 claims 1
- 208000032056 Radiation Fibrosis Syndrome Diseases 0.000 claims 1
- 206010067953 Radiation fibrosis Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 102100030053 Secreted frizzled-related protein 3 Human genes 0.000 claims 1
- 206010072170 Skin wound Diseases 0.000 claims 1
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 206010067269 Uterine fibrosis Diseases 0.000 claims 1
- 210000000683 abdominal cavity Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 230000001079 digestive effect Effects 0.000 claims 1
- 210000002919 epithelial cell Anatomy 0.000 claims 1
- 206010061989 glomerulosclerosis Diseases 0.000 claims 1
- 210000002216 heart Anatomy 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 208000023589 ischemic disease Diseases 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 210000003254 palate Anatomy 0.000 claims 1
- 239000000816 peptidomimetic Substances 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical class O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
- 210000000115 thoracic cavity Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0707348.9A GB0707348D0 (en) | 2007-04-17 | 2007-04-17 | Medicaments and methods for inhibition of scarring |
| PCT/GB2008/001345 WO2008125869A1 (en) | 2007-04-17 | 2008-04-17 | Secreted frizzled related protein 3 for use in the inhibition of scarring |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010524910A JP2010524910A (ja) | 2010-07-22 |
| JP2010524910A5 true JP2010524910A5 (https=) | 2011-02-03 |
Family
ID=38116837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010503583A Withdrawn JP2010524910A (ja) | 2007-04-17 | 2008-04-17 | 瘢痕の抑制に使用できる分泌性Ｆｒｉｚｚｌｅｄ関連タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100261659A1 (https=) |
| EP (1) | EP2148726A1 (https=) |
| JP (1) | JP2010524910A (https=) |
| AU (1) | AU2008237751A1 (https=) |
| CA (1) | CA2684368A1 (https=) |
| GB (1) | GB0707348D0 (https=) |
| WO (1) | WO2008125869A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009126888A2 (en) | 2008-04-10 | 2009-10-15 | Services Petroliers Schlumberger | Method for characterizing a geological formation traversed by a borehole |
| US8725477B2 (en) | 2008-04-10 | 2014-05-13 | Schlumberger Technology Corporation | Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics |
| US8311788B2 (en) | 2009-07-01 | 2012-11-13 | Schlumberger Technology Corporation | Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry |
| EP2723363B1 (en) | 2011-06-24 | 2018-08-29 | NoNO Inc. | Combination therapy for ischemia |
| US9241970B2 (en) * | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7049291B2 (en) * | 1996-10-11 | 2006-05-23 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and method of using tissue growth-inducing Frzb protein |
| EP1012262A4 (en) * | 1997-08-12 | 2002-11-06 | Human Genome Sciences Inc | Human frezzled-like protein |
| ES2433493T3 (es) * | 2003-06-25 | 2013-12-11 | Ottawa Hospital Research Institute | Métodos y composiciones para modular el crecimiento de células pluripotenciales y la diferenciación |
| WO2005070448A2 (en) * | 2004-01-21 | 2005-08-04 | Five Prime Therapeutics, Inc. | Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease |
| CA3022238A1 (en) * | 2005-08-19 | 2007-02-22 | Duke University | Stem cell derived factors for treating pathologic conditions |
-
2007
- 2007-04-17 GB GBGB0707348.9A patent/GB0707348D0/en not_active Ceased
-
2008
- 2008-04-17 AU AU2008237751A patent/AU2008237751A1/en not_active Abandoned
- 2008-04-17 CA CA002684368A patent/CA2684368A1/en not_active Abandoned
- 2008-04-17 EP EP08737006A patent/EP2148726A1/en not_active Withdrawn
- 2008-04-17 US US12/596,332 patent/US20100261659A1/en not_active Abandoned
- 2008-04-17 WO PCT/GB2008/001345 patent/WO2008125869A1/en not_active Ceased
- 2008-04-17 JP JP2010503583A patent/JP2010524910A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102946621B1 (ko) | 몬테루카스트와 펩티드의 새로운 접합체 | |
| JP5739908B2 (ja) | 血管形成関連の眼疾患の処置のための組成物および方法 | |
| US20100266532A1 (en) | Methods for inhibiting scarring | |
| WO2008133928A2 (en) | Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders | |
| BR112012001491A2 (pt) | composição de preparação externa para pele | |
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP2010524910A5 (https=) | ||
| RU2012136530A (ru) | Новые соединения, влияющие на пищевое поведение | |
| CN102596216A (zh) | 鼻炎治疗剂 | |
| WO2014179440A1 (en) | Accelerated healing of eye injuries by angiotensin peptides | |
| JP2009535329A5 (https=) | ||
| JP2013518090A5 (https=) | ||
| JP2025102868A (ja) | 炎症性サイトカインを阻害するための医薬組成物 | |
| JP2020524689A5 (https=) | ||
| KR20220079860A (ko) | 신규 펩티드 | |
| JP2020518287A5 (https=) | ||
| US20240226238A1 (en) | Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction | |
| JP2019519597A (ja) | 軟骨細胞の細胞外基質由来ペプチド | |
| JP2008526935A (ja) | 創傷治癒のためのｉｌ−１０関連ペプチド | |
| JP2026506026A (ja) | 新規多機能オリゴペプチド | |
| JP2009542609A5 (https=) | ||
| EP4213868A1 (en) | Method of reducing intraocular pressure | |
| JP2022516729A (ja) | ロイコトリエン受容体アンタゴニストを含有する新たな製剤 | |
| EP3167881A1 (en) | Locally administered ethamsylate as a medicament | |
| JP2022543598A5 (https=) |